• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough.一缕阳光:医生-行业关系的透明度还不够。
J Gen Intern Med. 2021 Oct;36(10):3194-3198. doi: 10.1007/s11606-021-06657-0. Epub 2021 Mar 10.
2
Deciphering the Sunshine Act: Transparency Regulation and Financial Conflicts in Health Care.解读《阳光法案》:医疗保健领域的透明度监管与财务冲突
Am J Law Med. 2017 Nov;43(4):303-343. doi: 10.1177/0098858817753403.
3
Disclosures Undisclosed.披露信息未公开。
J Bone Joint Surg Am. 2019 Jun 5;101(11):e50. doi: 10.2106/JBJS.18.01061.
4
Comparison of Conflicts of Interest among Published Hernia Researchers Self-Reported with the Centers for Medicare and Medicaid Services Open Payments Database.发表疝研究人员自我报告的利益冲突与医疗保险和医疗补助服务中心公开支付数据库的比较。
J Am Coll Surg. 2017 May;224(5):800-804. doi: 10.1016/j.jamcollsurg.2017.01.052. Epub 2017 Feb 4.
5
Assessing the impact of the Physician Payments Sunshine Act on pharmaceutical companies' payments to physicians.评估《医师阳光法案》对制药公司向医师支付款项的影响。
PLoS One. 2024 Aug 13;19(8):e0306886. doi: 10.1371/journal.pone.0306886. eCollection 2024.
6
Characteristics Of Biomedical Industry Payments To Teaching Hospitals.生物医学产业向教学医院支付的特点。
Health Aff (Millwood). 2020 Sep;39(9):1583-1591. doi: 10.1377/hlthaff.2020.00385.
7
Sunshine Act: shedding light on inaccurate disclosures at a gynecologic annual meeting.阳光法案:揭示妇科年会上不准确的披露情况
Am J Obstet Gynecol. 2016 Nov;215(5):661.e1-661.e7. doi: 10.1016/j.ajog.2016.06.015. Epub 2016 Jun 16.
8
Industry Financial Relationships in Neurosurgery in 2015: Analysis of the Sunshine Act Open Payments Database.2015 年神经外科学的行业财务关系:阳光法案公开支付数据库分析。
World Neurosurg. 2018 Jun;114:e920-e925. doi: 10.1016/j.wneu.2018.03.116. Epub 2018 Mar 23.
9
Information disclosure and the Physician Payments Sunshine Act.信息披露与《医师报酬阳光法案》
JAMA. 2011 Sep 14;306(10):1087; author reply 1087-8. doi: 10.1001/jama.2011.1298.
10
Bringing Transparency to Medicine: Exploring Physicians' Views and Experiences of the Sunshine Act.将透明度引入医学领域:探索医师对阳光法案的看法和经验。
Am J Bioeth. 2017 Jun;17(6):4-18. doi: 10.1080/15265161.2017.1313334.

引用本文的文献

1
The NHS and the pharmaceutical industry: High risk of harmful interactions.英国国家医疗服务体系(NHS)与制药行业:存在有害相互作用的高风险。
Future Healthc J. 2025 Jun 30;12(2):100257. doi: 10.1016/j.fhj.2025.100257. eCollection 2025 Jun.
2
Pharmaceutical Industry Payments to Patient Organizations in Poland: Analysis of the Patterns, Evolution, and Structure of Connections.波兰制药行业对患者组织的支付情况:关联模式、演变及结构分析
Int J Soc Determinants Health Health Serv. 2025 Apr;55(2):199-212. doi: 10.1177/27551938241305995. Epub 2024 Dec 26.
3
Commercial influences on patient and public involvement: a renewed call for research and action.商业对患者及公众参与的影响:对研究与行动的再次呼吁。
Health Promot Int. 2024 Dec 1;39(6). doi: 10.1093/heapro/daae188.
4
Can health impact assessment help tackle commercial determinants of health and support a wellbeing economy?健康影响评估能否有助于解决健康的商业决定因素问题并支持福利经济?
Health Promot Int. 2024 Dec 1;39(6). doi: 10.1093/heapro/daae135.
5
Conflict of interest and disclosure in healthcare: We can do better.医疗保健中的利益冲突与信息披露:我们可以做得更好。
J Appl Clin Med Phys. 2023 May;24(5):e14002. doi: 10.1002/acm2.14002. Epub 2023 Apr 23.
6
International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency.英国和日本制药行业支付披露的国际比较:对自我监管、公共监管和透明度的影响。
Global Health. 2023 Mar 3;19(1):14. doi: 10.1186/s12992-022-00902-9.
7
The intersection of the sunshine act, sutton's law, and the pandemic.《阳光法案》、萨顿定律与疫情的交叉点
Ann Allergy Asthma Immunol. 2022 Nov;129(5):542-543. doi: 10.1016/j.anai.2022.08.008.
8
How are declarations of interest working? A cross-sectional study in declarations of interest in healthcare practice in Scotland and England in 2020/2021.利益声明如何运作?2020/2021 年苏格兰和英格兰医疗实践中利益声明的横断面研究。
BMJ Open. 2022 Nov 4;12(11):e065365. doi: 10.1136/bmjopen-2022-065365.
9
Drivers of medicalization in the Canadian Adult Obesity Clinical Practice Guidelines.加拿大成人肥胖临床实践指南中的医学化驱动因素。
Can J Public Health. 2022 Oct;113(5):743-748. doi: 10.17269/s41997-022-00662-4. Epub 2022 Jul 15.
10
Physicians' attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey.医生对全国性自愿透明度数据库中制药公司支付款项披露态度的调查:一项横断面调查。
BMJ Open. 2022 Jun 24;12(6):e055963. doi: 10.1136/bmjopen-2021-055963.

本文引用的文献

1
Evaluating Financial Conflicts of Interest Among Contributors to Clinical Practice Guidelines of the American College of Obstetricians and Gynecologists.评估美国妇产科医师学会临床实践指南撰稿人之间的财务利益冲突。
J Am Osteopath Assoc. 2020 Jul 1;120(7):462-470. doi: 10.7556/jaoa.2020.059.
2
Financial ties between leaders of influential US professional medical associations and industry: cross sectional study.有影响力的美国专业医学协会领导人与行业之间的财务关联:横断面研究。
BMJ. 2020 May 27;369:m1505. doi: 10.1136/bmj.m1505.
3
Do Speakers Fully Disclose Potential Conflicts of Interest in Oral and Maxillofacial Surgery?口腔颌面外科的演讲者是否充分披露了潜在的利益冲突?
J Oral Maxillofac Surg. 2020 Oct;78(10):1669-1673. doi: 10.1016/j.joms.2020.03.010. Epub 2020 Mar 18.
4
Nonresearch Pharmaceutical Industry Payments to Oncology Physician Editors.非研究制药业向肿瘤学医师编辑的支付。
Oncologist. 2020 Jun;25(6):e986-e989. doi: 10.1634/theoncologist.2019-0828. Epub 2020 Apr 20.
5
All Disclosure is Good Disclosure: Patient Awareness of the Sunshine Act and Perceptions of Surgeon-Industry Relationships.所有披露都是好的披露:患者对阳光法案的认识和对外科医生-行业关系的看法。
Clin Spine Surg. 2020 Apr;33(3):E96-E100. doi: 10.1097/BSD.0000000000000915.
6
Association between physician characteristics and payments from industry in 2015-2017: observational study.2015-2017 年医生特征与行业支付之间的关联:观察性研究。
BMJ Open. 2019 Sep 20;9(9):e031010. doi: 10.1136/bmjopen-2019-031010.
7
Scope and nature of financial conflicts of interest between neurologists and industry: 2013-2016.神经科医生与产业界的财务利益冲突的范围与性质:2013-2016 年。
Neurology. 2019 Sep 3;93(10):438-449. doi: 10.1212/WNL.0000000000008067. Epub 2019 Aug 5.
8
Undisclosed financial conflicts of interest among authors of American Society of Clinical Oncology clinical practice guidelines.美国临床肿瘤学会临床实践指南作者的未披露财务利益冲突。
Cancer. 2019 Nov 15;125(22):4069-4075. doi: 10.1002/cncr.32408. Epub 2019 Jul 29.
9
Characteristics of Industry Payments to Ophthalmologists in the Open Payments Database.公开支付数据库中行业向眼科医生支付款项的特征。
JAMA Ophthalmol. 2019 Sep 1;137(9):1038-1044. doi: 10.1001/jamaophthalmol.2019.2456.
10
Association of Mandatory Disclosure Policies and Laws With Physician-Industry Financial Relationships.强制性披露政策和法律与医生-行业财务关系的关联。
JAMA Ophthalmol. 2019 May 1;137(5):523-530. doi: 10.1001/jamaophthalmol.2019.0085.

一缕阳光:医生-行业关系的透明度还不够。

A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough.

机构信息

School of Health Policy and Management, York University, Toronto, ON, Canada.

University Health Network, Toronto, Canada.

出版信息

J Gen Intern Med. 2021 Oct;36(10):3194-3198. doi: 10.1007/s11606-021-06657-0. Epub 2021 Mar 10.

DOI:10.1007/s11606-021-06657-0
PMID:33694070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8481515/
Abstract

Gifts from pharmaceutical and medical device companies to physicians in the United States have been reported since 2014, through the Physician Payments Sunshine Act. Although researchers have utilized these data to publish many studies on conflicts of interest (COIs) and prescribing behavior, there is no evidence that physician behavior regarding COI has changed, or that employers, meeting organizers, or medical journals are excluding physicians based on conflicts of interest. Disclosure is necessary but not sufficient to address the damage that industry relationships causes to medical knowledge and public health.

摘要

自 2014 年以来,通过《医师薪酬阳光法案》,一直有报道称美国的制药和医疗器械公司向医生赠送礼物。尽管研究人员利用这些数据发表了许多关于利益冲突(COI)和处方行为的研究,但没有证据表明医生在 COI 方面的行为发生了变化,或者雇主、会议组织者或医学期刊根据利益冲突排除了医生。披露是必要的,但不足以解决行业关系对医学知识和公共卫生造成的损害。